Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

RXST

RxSight Inc

May 16 • 04:00PM ET

62.26

Dollar change -2.03
Percentage change -3.16	%

Healthcare • Medical Devices • USA • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWO DWAS SCHA VTWO VHT IWC FYX

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.25	Insider Own	5.46%	Shs Outstand	38.98M	Perf Week	1.37%
Market Cap	2.43B	Forward P/E	-	EPS next Y	-0.50	Insider Trans	-41.83%	Shs Float	36.85M	Perf Month	17.85%
Income	-44.50M	PEG	-	EPS next Q	-0.23	Inst Own	78.72%	Short Float	4.27%	Perf Quarter	16.27%
Sales	101.10M	P/S	24.00	EPS this Y	42.05%	Inst Trans	-0.96%	Short Ratio	3.55	Perf Half Y	128.90%
Book/sh	4.41	P/B	14.11	EPS next Y	39.34%	ROA	-23.07%	Short Interest	1.57M	Perf Year	164.82%
Cash/sh	3.22	P/C	19.36	EPS next 5Y	19.00%	ROE	-28.81%	52W Range	20.66 - 66.54	Perf YTD	54.41%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-26.99%	52W High	-6.43%	Beta	1.27
Dividend TTM	-	Quick Ratio	8.18	Sales past 5Y	201.89%	Gross Margin	63.39%	52W Low	201.36%	ATR (14)	3.17
Dividend Ex-Date	-	Current Ratio	9.20	EPS Y/Y TTM	42.91%	Oper. Margin	-47.14%	RSI (14)	61.02	Volatility	5.16% 5.30%
Employees	374	Debt/Eq	0.02	Sales Y/Y TTM	75.67%	Profit Margin	-44.01%	Recom	1.00	Target Price	72.75
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	40.85%	Payout	-	Rel Volume	0.70	Prev Close	64.29
Sales Surprise	7.09%	EPS Surprise	15.05%	Sales Q/Q	68.75%	Earnings	May 06 AMC	Avg Volume	442.68K	Price	62.26
SMA20	9.11%	SMA50	16.01%	SMA200	56.99%	Trades		Volume	310,495	Change	-3.16%

Date	Action	Analyst	Rating Change	Price Target Change
May-07-24	Reiterated	BTIG Research	Buy	$61 → $72
Dec-13-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$31 → $42
Dec-12-23	Initiated	Stifel	Buy	$40
Dec-04-23	Initiated	Morgan Stanley	Overweight	$36
Apr-13-23	Initiated	Oppenheimer	Outperform	$23
Dec-12-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$20 → $14
Apr-08-22	Initiated	Needham	Buy	$18

May-13-24 04:58PM	RxSight Raises $115 Million From Public Offering of Shares (MT Newswires)
04:05PM	RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
May-08-24 09:15PM	RxSight, Inc. Announces Pricing of Public Offering of Common Stock (GlobeNewswire)
04:05PM	RxSight, Inc. Announces Proposed Public Offering of Common Stock (GlobeNewswire)
May-07-24 12:17PM	Wells Fargo Adjusts RxSight Price Target to $68 From $61, Maintains Overweight Rating (MT Newswires)
08:50AM	Loading…
08:50AM	RxSight, Inc. (NASDAQ:RXST) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:49AM	Needham Adjusts Price Target on RxSight to $75 From $64, Maintains Buy Rating (MT Newswires)
08:48AM	Oppenheimer Adjusts RxSight Price Target to $72 From $61, Maintains Outperform Rating (MT Newswires)
08:28AM	BTIG Adjusts Price Target on RxSight to $72 From $61, Maintains Buy Rating (MT Newswires)
06:42AM	Q1 2024 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents)
04:26AM	RxSight Q1 Adjusted Loss Narrows, Revenue Rises (MT Newswires)
03:10AM	RxSight Inc (RXST) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-06-24 05:37PM	RxSight Inc (RXST) Surpasses Analyst Revenue Forecasts in Q1 2024 (GuruFocus.com)
05:06PM	Rxsight Insider Sold Shares Worth $2,405,872, According to a Recent SEC Filing (MT Newswires)
04:05PM	RxSight, Inc. Reports First Quarter 2024 Financial Results (GlobeNewswire)
05:03PM	Loading…
May-02-24 05:03PM	Rxsight Insider Sold Shares Worth $526,913, According to a Recent SEC Filing (MT Newswires) +5.17%
May-01-24 04:05PM	RxSight, Inc. to Present at the Bank of America Healthcare Conference (GlobeNewswire) +8.77%
Apr-22-24 04:05PM	RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024 (GlobeNewswire)
Apr-04-24 04:05PM	RxSight Announces Commercial Launch of its Newest Light Adjustable Lens , the LAL+ , and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting (GlobeNewswire)
Mar-27-24 04:05PM	RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Feb-29-24 07:05PM	RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference (GlobeNewswire)
11:09AM	RxSight, Inc. (NASDAQ:RXST) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:36AM	Q4 2023 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-28-24 04:38PM	RxSight Inc (RXST) Reports Significant Revenue Growth in Q4 and Full Year 2023 (GuruFocus.com)
04:05PM	RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-14-24 04:05PM	RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 (GlobeNewswire)
Jan-19-24 05:01PM	Director Shweta Maniar Sells 6,399 Shares of RxSight Inc (GuruFocus.com)
Jan-12-24 03:16PM	3 Stocks to Buy BEFORE They Become Household Names (InvestorPlace)
Jan-09-24 06:19PM	RxSight, Inc. (RXST) Just Overtook the 20-Day Moving Average (Zacks)
Jan-07-24 10:00AM	RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance (GlobeNewswire)
04:05PM	Loading…
Dec-27-23 04:05PM	RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-15-23 09:30AM	RxSight, Inc. (RXST) Recently Broke Out Above the 50-Day Moving Average (Zacks)
Nov-12-23 10:26AM	RxSight, Inc. (NASDAQ:RXST) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-10-23 07:42AM	Q3 2023 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents) +6.22%
Nov-09-23 04:05PM	RxSight, Inc. Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-02-23 09:00AM	RxSight, Inc. Educational and Product Announcements for AAO 2023 (GlobeNewswire)
Oct-26-23 04:05PM	RxSight, Inc. to Report Third Quarter Financial Results on November 9, 2023 (GlobeNewswire) -5.43%
Sep-07-23 09:35AM	RxSight, Inc. (RXST) Crossed Above the 20-Day Moving Average: What That Means for Investors (Zacks)
Aug-23-23 04:05PM	RxSight, Inc. to Present at the Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-22-23 05:20PM	Has Alcon (ALC) Outpaced Other Medical Stocks This Year? (Zacks)
Aug-18-23 09:23AM	The Zacks Analyst Blog Highlights Abcam, Integer Holdings and RxSight (Zacks)
Aug-17-23 08:37AM	3 Medical Device Stocks With Potential to Fight Deflation Risk (Zacks)
Aug-08-23 08:44AM	RxSight, Inc. (NASDAQ:RXST) Q2 2023 Earnings Call Transcript (Insider Monkey)
06:21AM	Q2 2023 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-23 06:15PM	RxSight, Inc. (RXST) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	RxSight, Inc. Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-25-23 04:05PM	RxSight, Inc. to Report Second Quarter Financial Results on August 7, 2023 (GlobeNewswire)
Jun-30-23 08:31AM	Strength Seen in RxSight, Inc. (RXST): Can Its 9.6% Jump Turn into More Strength? (Zacks)
Jun-27-23 08:38AM	Alphatec (ATEC) Surges 8.8%: Is This an Indication of Further Gains? (Zacks)
Jun-18-23 10:53AM	Investors in RxSight (NASDAQ:RXST) have seen respectable returns of 79% over the past year (Simply Wall St.)
May-10-23 07:52AM	Q1 2023 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents) +9.87%
May-09-23 06:15PM	RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	RxSight, Inc. Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-03-23 10:00AM	Steris (STE) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
May-02-23 10:02AM	Will RxSight, Inc. (RXST) Report Negative Earnings Next Week? What You Should Know (Zacks)
Apr-26-23 06:33PM	2 Strong Buy Stocks Oppenheimer Predicts Will Surge at Least 30% (TipRanks)
04:05PM	RxSight, Inc. to Present at the Bank of America Healthcare Conference (GlobeNewswire)
Apr-25-23 04:05PM	RxSight, Inc. to Report First Quarter Financial Results on May 9, 2023 (GlobeNewswire)
Apr-24-23 04:05PM	Multiple Surgeon Presentations to Highlight RxSight® Light Adjustable Lens System at Upcoming American Society of Cataract and Refractive Surgery Annual Meeting (GlobeNewswire)
Apr-18-23 11:26AM	RxSight, Inc. (NASDAQ:RXST) Not Lagging Industry On Growth Or Pricing (Simply Wall St.)
Apr-11-23 12:00PM	Here's Why RxSight, Inc. (RXST) is a Great Momentum Stock to Buy (Zacks)
Apr-05-23 04:05PM	RxSight, Inc. to Present at the Needham Healthcare Conference (GlobeNewswire)
Mar-13-23 09:55AM	How Much Upside is Left in RxSight, Inc. (RXST)? Wall Street Analysts Think 25.69% (Zacks)
Mar-08-23 07:21AM	RxSight, Inc. (NASDAQ:RXST) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-07-23 08:23AM	Q4 2022 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents)
05:16AM	RxSight, Inc.'s (NASDAQ:RXST) biggest owners are individual investors who got richer after stock soared 14% last week (Simply Wall St.)
Mar-06-23 04:05PM	RxSight, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire) +12.96%
Feb-28-23 04:05PM	RxSight, Inc. to Present at the Oppenheimer Healthcare Conference (GlobeNewswire)
Feb-21-23 04:05PM	RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 6, 2023 (GlobeNewswire)
Feb-14-23 04:05PM	RxSight, Inc. Announces Full Exercise of Underwriters Option to Purchase Additional Shares and Closing of its Public Offering of Common Stock (GlobeNewswire)
Feb-08-23 12:45AM	RxSight, Inc. Announces Pricing of Public Offering of Common Stock (GlobeNewswire) -7.70%
Feb-07-23 04:05PM	RxSight, Inc. Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Jan-09-23 08:56AM	Investing in RxSight (NASDAQ:RXST) a year ago would have delivered you a 12% gain (Simply Wall St.)
Jan-08-23 04:00PM	RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial and Operational Results (GlobeNewswire)
Dec-31-22 06:15AM	RxSight, Inc. (NASDAQ:RXST) Q3 2022 Earnings Call Transcript (Insider Monkey)
Dec-28-22 04:05PM	RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-22-22 09:40AM	Has IntraCellular Therapies (ITCI) Outpaced Other Medical Stocks This Year? (Zacks) +5.33%
Dec-06-22 09:40AM	Is RxSight (RXST) Stock Outpacing Its Medical Peers This Year? (Zacks) -7.66%
Dec-02-22 09:55AM	Does RxSight, Inc. (RXST) Have the Potential to Rally 43% as Wall Street Analysts Expect? (Zacks)
Nov-16-22 09:55AM	Wall Street Analysts Predict a 45% Upside in RxSight, Inc. (RXST): Here's What You Should Know (Zacks)
Nov-09-22 06:10AM	RxSight Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.)
Nov-07-22 06:15PM	RxSight, Inc. (RXST) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +7.86%
04:05PM	RxSight, Inc. Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Nov-03-22 10:00AM	Sight Sciences, Inc. (SGHT) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Oct-31-22 10:01AM	RxSight, Inc. (RXST) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Oct-24-22 04:05PM	RxSight, Inc. to Report Third Quarter 2022 Financial Results on November 7, 2022 (GlobeNewswire)
Oct-12-22 06:56AM	RxSight, Inc. (NASDAQ:RXST) drops to US$276m and insiders who purchased earlier this year lose another US$20k (Simply Wall St.)
Aug-24-22 04:05PM	RxSight, Inc. to Present at the Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-22-22 01:45PM	Individual investors own 27% of RxSight, Inc. (NASDAQ:RXST) shares but private equity firms control 32% of the company (Simply Wall St.)
Aug-08-22 11:30PM	RxSight, Inc. (RXST) Q2 2022 Earnings Call Transcript (Motley Fool)
05:35PM	RxSight, Inc. (RXST) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:10PM	RxSight, Inc. Files Shelf Registration Statement and Announces $50 Million At-The-Market Equity Offering Program (GlobeNewswire)
04:05PM	RxSight, Inc. Reports Second Quarter 2022 Financial Results (GlobeNewswire)
Aug-02-22 06:27AM	The past year for RxSight (NASDAQ:RXST) investors has not been profitable (Simply Wall St.)
Jul-25-22 04:05PM	RxSight, Inc. to Report Second Quarter 2022 Financial Results on August 8, 2022 (GlobeNewswire)
May-08-22 08:21AM	RxSight, Inc. (NASDAQ:RXST) Just Reported, And Analysts Assigned A US$18.40 Price Target (Simply Wall St.)
May-06-22 11:00AM	RxSight, Inc. (RXST) Q1 2022 Earnings Call Transcript (Motley Fool) +6.97%
May-05-22 04:05PM	RxSight, Inc. Reports First Quarter 2022 Financial Results (GlobeNewswire) -10.54%
May-04-22 03:51PM	RxSight, Inc. (NASDAQ:RXST) insiders placed bullish bets worth US$5.6m in the last 12 months (Simply Wall St.)
Apr-22-22 09:00AM	RxSight, Inc. to Present at the Bank of America Healthcare Conference (GlobeNewswire) -8.32%

RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kurtz Ronald M MD	President & CEO	May 03 '24	Sale	60.15	40,000	2,405,872	764,610	May 06 05:02 PM
Thunen Shelley B	Chief Financial Officer	May 01 '24	Option Exercise	15.60	10,247	159,836	23,938	May 02 04:58 PM
Thunen Shelley B	Chief Financial Officer	May 01 '24	Sale	52.69	10,000	526,913	13,938	May 02 04:58 PM
Thunen Shelley B	Chief Financial Officer	Apr 01 '24	Sale	49.90	20,000	997,946	8,402	Apr 02 04:18 PM
Thunen Shelley B	Chief Financial Officer	Mar 01 '24	Option Exercise	15.60	10,000	155,983	23,691	Mar 05 04:05 PM
Thunen Shelley B	Chief Financial Officer	Mar 01 '24	Sale	56.37	10,000	563,726	13,691	Mar 05 04:05 PM
Goldshleger Ilya	Chief Operating Officer	Feb 16 '24	Option Exercise	23.04	10,000	230,400	36,475	Feb 16 05:00 PM
Goldshleger Ilya	Chief Operating Officer	Feb 16 '24	Sale	55.50	10,000	555,000	26,475	Feb 16 05:00 PM
Goldshleger Ilya	Chief Operating Officer	Feb 15 '24	Option Exercise	23.04	10,000	230,400	36,475	Feb 16 05:00 PM
Goldshleger Ilya	Chief Operating Officer	Feb 15 '24	Sale	53.50	10,000	535,000	26,475	Feb 16 05:00 PM
Goldshleger Ilya	Chief Operating Officer	Feb 14 '24	Option Exercise	23.04	5,000	115,200	31,475	Feb 16 05:00 PM
Tammenoms Bakker Juliet	Director	Feb 14 '24	Buy	51.29	4,000	205,153	29,840	Feb 15 04:15 PM
Goldshleger Ilya	Chief Operating Officer	Feb 14 '24	Sale	52.00	5,000	260,000	26,475	Feb 16 05:00 PM
Tammenoms Bakker Juliet	Director	Feb 12 '24	Buy	50.38	4,000	201,520	25,840	Feb 15 04:15 PM
Goldshleger Ilya	Chief Operating Officer	Feb 09 '24	Option Exercise	20.90	10,365	216,598	36,840	Feb 12 06:02 PM
Goldshleger Ilya	Chief Operating Officer	Feb 09 '24	Sale	50.74	10,365	525,939	26,475	Feb 12 06:02 PM
Thunen Shelley B	Chief Financial Officer	Feb 06 '24	Option Exercise	14.95	15,875	237,331	29,566	Feb 07 05:18 PM
Thunen Shelley B	Chief Financial Officer	Feb 06 '24	Sale	47.47	15,875	753,574	13,691	Feb 07 05:18 PM
Thunen Shelley B	Chief Financial Officer	Feb 05 '24	Option Exercise	10.38	16,025	166,365	22,816	Feb 07 05:18 PM
Thunen Shelley B	Chief Financial Officer	Feb 05 '24	Sale	47.02	9,125	429,087	13,691	Feb 07 05:18 PM
Goldshleger Ilya	Chief Operating Officer	Feb 01 '24	Option Exercise	19.24	7,129	137,181	33,604	Feb 02 04:47 PM
LINK WILLIAM J PHD	Director	Feb 01 '24	Sale	49.67	28,250	1,403,120	24,248	Feb 02 04:49 PM
Weinberg Eric	Chief Commercial Officer	Feb 01 '24	Sale	50.00	10,000	500,004	299,978	Feb 02 04:47 PM
Goldshleger Ilya	Chief Operating Officer	Feb 01 '24	Sale	49.29	7,129	351,411	26,475	Feb 02 04:47 PM
Thunen Shelley B	Chief Financial Officer	Jan 26 '24	Option Exercise	13.75	36,272	498,652	38,563	Jan 29 05:36 PM
Thunen Shelley B	Chief Financial Officer	Jan 26 '24	Sale	47.11	31,772	1,496,706	6,791	Jan 29 05:36 PM
Goldshleger Ilya	Chief Operating Officer	Jan 22 '24	Option Exercise	18.90	5,000	94,500	31,475	Jan 22 07:48 PM
Weinberg Eric	Chief Commercial Officer	Jan 22 '24	Sale	48.00	10,000	480,006	309,978	Jan 22 07:50 PM
Goldshleger Ilya	Chief Operating Officer	Jan 22 '24	Sale	48.00	5,000	240,000	26,475	Jan 22 07:48 PM
Maniar Shweta	Director	Jan 18 '24	Sale	45.72	6,399	292,555	12,130	Jan 19 04:01 PM
Goldshleger Ilya	Chief Operating Officer	Jan 09 '24	Option Exercise	18.90	5,000	94,500	31,475	Jan 10 05:29 PM
Weinberg Eric	Chief Commercial Officer	Jan 09 '24	Sale	46.00	10,000	460,000	319,978	Jan 10 05:28 PM
Goldshleger Ilya	Chief Operating Officer	Jan 09 '24	Sale	47.00	5,000	235,000	26,475	Jan 10 05:29 PM
Goldshleger Ilya	Chief Operating Officer	Jan 08 '24	Option Exercise	15.08	15,000	226,200	41,475	Jan 09 04:05 PM
Kurtz Ronald M MD	President & CEO	Jan 08 '24	Sale	44.25	62,500	2,765,631	804,610	Jan 09 04:08 PM
Warner Robert Keith	Director	Jan 08 '24	Sale	42.69	23,750	1,013,894	0	Jan 09 04:10 PM
Goldshleger Ilya	Chief Operating Officer	Jan 08 '24	Sale	43.33	15,000	650,000	26,475	Jan 09 04:05 PM
Weinberg Eric	Chief Commercial Officer	Jan 08 '24	Sale	42.00	10,000	420,000	329,978	Jan 09 04:12 PM
Maniar Shweta	Director	Jan 08 '24	Sale	45.00	6,418	288,810	18,529	Jan 09 04:09 PM
Corley Jesse Anderson	Director	Jan 08 '24	Sale	45.03	2,000	90,059	11,625	Jan 09 04:02 PM
Thunen Shelley B	Chief Financial Officer	Jan 02 '24	Option Exercise	15.60	10,000	155,983	12,291	Jan 03 04:11 PM
Thunen Shelley B	Chief Financial Officer	Jan 02 '24	Sale	39.24	10,000	392,409	2,291	Jan 03 04:11 PM
Kurtz Ronald M MD	President & CEO	Dec 27 '23	Sale	41.09	22,500	924,498	867,110	Dec 29 04:57 PM
Goldshleger Ilya	Chief Operating Officer	Dec 22 '23	Option Exercise	15.08	5,000	75,400	31,475	Dec 26 04:10 PM
Goldshleger Ilya	Chief Operating Officer	Dec 22 '23	Sale	40.00	5,000	200,000	26,475	Dec 26 04:10 PM
Weinberg Eric	Chief Commercial Officer	Dec 22 '23	Sale	40.00	1,285	51,400	339,978	Dec 26 04:11 PM
Goldshleger Ilya	Chief Operating Officer	Dec 18 '23	Option Exercise	14.14	10,937	154,670	37,412	Dec 20 06:07 PM
Goldshleger Ilya	Chief Operating Officer	Dec 18 '23	Sale	39.02	10,937	426,710	26,475	Dec 20 06:07 PM
Thunen Shelley B	Chief Financial Officer	Dec 15 '23	Option Exercise	15.60	20,000	312,000	22,291	Dec 18 07:09 PM
Thunen Shelley B	Chief Financial Officer	Dec 15 '23	Sale	39.35	20,000	786,984	2,291	Dec 18 07:09 PM
Thunen Shelley B	Chief Financial Officer	Dec 15 '23	Sale	39.32	20,000	786,326	28,402	Dec 18 07:09 PM
Weinberg Eric	Chief Commercial Officer	Dec 15 '23	Sale	40.01	8,715	348,711	341,263	Dec 19 08:14 PM
Kurtz Ronald M MD	President & CEO	Dec 14 '23	Sale	39.70	40,000	1,588,186	889,610	Dec 18 07:07 PM
Corley Jesse Anderson	Director	Dec 14 '23	Sale	40.12	12,000	481,469	13,625	Dec 18 07:08 PM
Warner Robert Keith	Director	Dec 11 '23	Sale	35.08	5,498	192,845	23,750	Dec 12 06:49 PM
Warner Robert Keith	Director	Dec 08 '23	Sale	35.01	14,502	507,706	29,248	Dec 12 06:49 PM
Tammenoms Bakker Juliet	Director	Nov 29 '23	Sale	29.77	349,245	10,398,665	0	Nov 30 07:32 PM
Tammenoms Bakker Juliet	Director	Nov 28 '23	Sale	29.62	145,068	4,297,030	349,245	Nov 30 07:32 PM
Tammenoms Bakker Juliet	Director	Nov 15 '23	Sale	27.20	400,000	10,878,160	494,313	Nov 16 07:31 PM
Tammenoms Bakker Juliet	Director	Nov 14 '23	Sale	27.13	100,000	2,712,590	894,313	Nov 16 07:31 PM
Tammenoms Bakker Juliet	Director	Sep 11 '23	Sale	30.01	2,950	88,525	20,223	Sep 11 06:15 PM
Tammenoms Bakker Juliet	Director	Sep 08 '23	Sale	30.25	10,033	303,461	23,173	Sep 11 06:15 PM
Tammenoms Bakker Juliet	Director	Sep 07 '23	Sale	30.10	19,967	600,983	33,206	Sep 11 06:15 PM
Maniar Shweta	Director	Aug 29 '23	Sale	28.06	4,292	120,451	24,947	Aug 29 05:10 PM
Tammenoms Bakker Juliet	Director	Aug 25 '23	Sale	29.25	16,208	474,129	53,173	Aug 28 07:44 PM
Tammenoms Bakker Juliet	Director	Aug 18 '23	Sale	29.07	14,651	425,877	68,411	Aug 18 04:08 PM
Tammenoms Bakker Juliet	Director	Aug 17 '23	Sale	30.06	18,484	555,694	83,062	Aug 18 04:08 PM
Goldshleger Ilya	Chief Operating Officer	Jul 26 '23	Option Exercise	3.93	25,475	100,000	26,475	Jul 27 04:44 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RXST

RxSight Inc

Upgrade your FINVIZ experience